fluorouracil has been researched along with Hematoma in 8 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We reported two cases of retroperitoneal hematoma in patients who received a combination of anticoagulant therapy and 5-fluorouracil (5-FU)." | 7.73 | Two cases of retroperitoneal hematoma caused by combination of anticoagulant therapy and 5-fluorouracil. ( Furutani, K; Furutani, S; Kashihara, K; Minato, M; Morita, N; Murase, T; Nishitani, H; Otsuka, H; Tagashira, H; Tsujikawa, T; Yoneda, K, 2005) |
| "We reported two cases of retroperitoneal hematoma in patients who received a combination of anticoagulant therapy and 5-fluorouracil (5-FU)." | 3.73 | Two cases of retroperitoneal hematoma caused by combination of anticoagulant therapy and 5-fluorouracil. ( Furutani, K; Furutani, S; Kashihara, K; Minato, M; Morita, N; Murase, T; Nishitani, H; Otsuka, H; Tagashira, H; Tsujikawa, T; Yoneda, K, 2005) |
| "Patients with stage IV colorectal cancer and peritoneal carcinomatosis are increasingly treated with curative intent and perioperative systemic chemotherapy combined with targeted therapy." | 1.40 | Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin. ( Elias, D; Eveno, C; Gayat, E; Glehen, O; Goéré, D; Passot, G; Pocard, M; Soyer, P, 2014) |
| "A 59-years-old woman with metastatic rectal cancer treated with bevacizumab, who developed low back pain after 11 cycles of chemotherapy." | 1.38 | Perirenal hematoma associated with bevacizumab treatment. ( Hayashi, H; Nakagawa, K; Okamoto, I, 2012) |
| "Moreover, circulating tumor cells were demonstrated by flow cytometry." | 1.38 | [Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012]. ( Horger, M; Jaschonek, K; Kanz, L; Kopp, HG; Kurth, R; Mayer, F; Orgel, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Smolenschi, C | 1 |
| Tazdait, M | 1 |
| Kuhn, E | 1 |
| Boige, V | 1 |
| Eveno, C | 1 |
| Passot, G | 1 |
| Goéré, D | 1 |
| Soyer, P | 1 |
| Gayat, E | 1 |
| Glehen, O | 1 |
| Elias, D | 1 |
| Pocard, M | 1 |
| Dominici, LS | 1 |
| Kuerer, HM | 1 |
| Babiera, G | 1 |
| Hahn, KM | 1 |
| Perkins, G | 1 |
| Middleton, L | 1 |
| Ramirez, MM | 1 |
| Yang, W | 1 |
| Hortobagyi, GN | 1 |
| Theriault, RL | 1 |
| Litton, JK | 1 |
| Hayashi, H | 1 |
| Okamoto, I | 1 |
| Nakagawa, K | 1 |
| Orgel, M | 1 |
| Horger, M | 1 |
| Kurth, R | 1 |
| Kanz, L | 1 |
| Jaschonek, K | 1 |
| Mayer, F | 1 |
| Kopp, HG | 1 |
| Morita, N | 1 |
| Kashihara, K | 1 |
| Tagashira, H | 1 |
| Otsuka, H | 1 |
| Yoneda, K | 1 |
| Murase, T | 1 |
| Tsujikawa, T | 1 |
| Furutani, S | 1 |
| Furutani, K | 1 |
| Minato, M | 1 |
| Nishitani, H | 1 |
| Antonovic, R | 1 |
| Rösch, J | 1 |
| Dotter, CT | 1 |
| Cohn, I | 1 |
1 trial available for fluorouracil and Hematoma
| Article | Year |
|---|---|
Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Blood Cell Count; Blood Platelets; Blood Transfusion; Breast Neoplasms; Clinical Trials | 1968 |
7 other studies available for fluorouracil and Hematoma
| Article | Year |
|---|---|
Bilateral adrenal haematoma complicated by adrenal insufficiency in a patient treated with bevacizumab.
Topics: Adrenal Insufficiency; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neopl | 2021 |
Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
Topics: Abdominal Abscess; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combin | 2014 |
Wound complications from surgery in pregnancy-associated breast cancer (PABC).
Topics: Abscess; Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Diseases; Breast Neop | 2010 |
Perirenal hematoma associated with bevacizumab treatment.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2012 |
[Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2012 |
Two cases of retroperitoneal hematoma caused by combination of anticoagulant therapy and 5-fluorouracil.
Topics: Aged; Anticoagulants; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Interactions; Esophag | 2005 |
Complications of percutaneous transaxillary catheterization for arteriography and selective chemotherapy.
Topics: Adult; Aged; Angiography; Aortography; Arterial Occlusive Diseases; Axillary Artery; Catheterization | 1976 |